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Abstract 
We previously demonstrated that a spontaneous smooth small-colony variant of Brucella abortus S19 
is characterized by increased in vivo persistence and the differential expression of a gene predicted to 
encode a galactoside transport ATP binding protein (mglA). In order to further investigate the role of 
this gene in the context of its flanking regions, we analyzed the respective DNA sequences from the 
formerly described B. abortus S19 as well as from avirulent B. neotomae 5K33 and compared these 
with published data from other Brucella species. Deletion mutagenesis of mglA in the large-colony 
variant of B. abortus S19 resulted in increased tolerance of the deletion mutant to a hyperosmotic 
(toxic), galactose-containing medium as well as to oxidative stress (H2O2). Whilst the deletion mutant 
is characterized by reduced growth on solid Fe
3+
-containing minimal medium (small-colony 
morphology), in vivo studies in mice demonstrated statistical significant differences in the bacterial 
load of spleens in the pre-immune, but not in the late phase of the infection. 
 
Introduction 
Bacteria of the genus Brucella cause chronic infections in both humans and a variety of animal 
species. We previously characterized a spontaneous smooth small-colony variant of B. abortus S19 
which demonstrates not only a reduced growth rate in vitro, but, most importantly, also a less effective 
clearance from spleens and livers of experimentally infected mice ( Hort et al., 2003). Using a 
differential approach to analyze mRNA-derived cDNA, we identified a molecular difference in the 
transcription of a gene predicted to encode for a formerly described galactoside transport ATP binding 
protein, mglA, in the small-colony variant ( Jacob et al., 2006). 
In order to further characterize the genetic basis of (adoptive) tolerance of Brucella to host immune 
responses, we analyzed the mglA gene and its flanking regions by means of PCR-assisted DNA 
sequencing in B. abortus S19 and the avirulent B. neotomae 5K33. The comparison of these data with 
published mglA sequences of B. melitensis 16M ( DelVecchio et al., 2002), B. abortus 2308, B. 
abortus 9–941 ( Halling et al., 2005), B. suis ( Paulsen et al., 2002), B. canis ( Wattam et al., 2009), B. 
ovis ( Wattam et al., 2009), Brucella sp. 83/13 (Broad Institute of MIT and Harvard, Cambridge, USA, 
http://www.broad.mit.edu/annotation/genome/brucella_group/GenomeDescriptions.html#Brucella_sp_
83_13_v1), and B. microti CCM 4915 ( Audic et al., 2009) revealed various differences within these 
species. 
To substantiate the assumption of a role of mglA in pathogenesis and tolerance to hostile 
environments, we generated a mglA deletion mutant of the formerly described ( Jacob et al., 2006) 
large-colony variant of B. abortus S19. The behaviour of the mutant was characterized by assessing 
its growth rate on galactose and Fe
3+
-containing minimal media and the tolerance to both a 
hyperosmotic medium and oxidative stress. Moreover, the BALBc mouse model was used to test for in 
vivo behaviour. 
 
Material and methods 
Bacterial strains 
B. abortus 2308, B. abortus S19, B. neotomae 5K33 ( Stoenner and Lackman, 1957) as well as B. 
microti CCM 4915 ( Scholz et al., 2008) were grown in trypticase soy broth (TSB) as described ( Hort 
et al., 2003) and were used for chromosomal DNA preparation according to the High Pure PCR 
Template Preparation Kit (Roche, Mannheim, Germany). Minimal basic medium (MBM) is a 
modification of Triple Sugar Iron (TSI) available from OXOID Ltd. (Basingstoke, UK, Cat. no. CM 277). 
Molecular biological techniques 
PCR was used to create overlapping PCR products of the following target genes of Brucella: nirK, 
nirV, nnrA, periplasmic protein precursor, mglA, and permease protein ( Fig. 1). That was performed 
using an UNO-Thermoblock (Biometra, Göttingen, Germany). The PCR fragments were analyzed by 
gel electrophoresis in 1% BIO-RAD Ready-agarose TBE mini gel (BIO RAD Cat. no. 161–3010, 
1 V/cm, 24 h). The cycling conditions and the complete list of primers are available on request. PCR 
products were sequenced with the ABI PRISM 3100 Genetic Analyzer using the PCR Cycle 
sequencing Big-DYE (V. 3.0) Terminator Protocol (PE Applied Biosystems, Foster City, CA, USA). The 
sequences were exported to and assembled, with respect to primary DNA sequence comparisons, 
using Sequencher (V. 4.6) DNA analysis software (Gene Code Corp., Ann Arbor, MI, USA). More 





For deletion mutagenesis, a PCR fragment containing mglA was cloned into pJQ200mp18 ( Quandt 
and Hynes, 1993). The resulting plasmid p10/29 was then digested by MvI1269I/PagI yielding p10/29 
which contained Δ mglA, characterized by a deletion of 460–652 bp with respect to the intact mglA. 
Then, p10/29 (Δ mglA) was mobilized into B. abortus S19A strain (the large-colony variant) from E. 
coli strain S17-1(-pir) ( Simon et al., 1983) by conjugation on Brain Heart Agar (BHA) for 2 days at 
37 °C (5% CO2 vol.). Transconjugants were selected on BHA supplemented with nalidixic acid 
(5 μg/ml), polymixin-B (5 IU/ml), and gentamicin (50 μg/ml). Single colonies growing on this medium 
were subcultured on BHA + antibiotics with and without 5% sucrose. 
Gentamicin-resistant colonies were selected, DNA extracted (High Pure PCR Template Preparation 
Kit, Roche) and analyzed by PCR using mglA-specific primers to confirm the deletion of the internal 
MvI1269I/PagI fragment in mglA ( Fig. 2). 
In vitro tolerance assays 
In vitro tolerance assays were performed in ‘F1-medium’ consisting of 17 g casein peptone, 3 g 
soybean meal peptone, 2 g yeast extract, 49 g potassium acetate, 9 g M9 minimal media salt A, and 
1.7 g M9 minimal media salt B (MP Biomedicals, Illkirch, France) per litre. The medium was adjusted 
to pH 7.0 and subsequently autoclaved. Finally, the sugar content was adjusted to be 10 mM by 
means of addition of sterile filtered galactose solution. 1 × 10
9
 viable cells of each B. abortus 2308, B. 
abortus S19, B. neotomae 5K33, and B. abortus S19 A Δ-mglA 3.14 were used to yield an initial 
experimental inoculum of 1 × 10
7
 cells/ml. Experiments were performed at 37 °C under an oxygen-
depleted and CO2-enriched atmosphere in an anaerobic jar (Anaerocult C, Merck, Darmstadt, 
Germany). Survival of cells was determined by taking aliquots of 100 μl each and plating on trypticase 
soy agar (TSA) on days 1, 3, 6, 8, and 10 ( Fig. 5). 
In another set of experiments, H2O2 in concentrations of (0.6, 0.3, 0.15, 0.075% each) was added to 
RPMI 1640 medium to test tolerance to oxygenic stress. 
Modified triple sugar iron agar (TSI, No. 227, Oxoid, Germany) was used to test for growth on this 
medium containing 1.8 g/l (10 mM) galactose and/or Fe
3+
 at 37 °C under both aerobic and 
microaerobic conditions. Fig. 4 shows Brucella which were grown aerobically only. 
In vivo behaviour of bacterial strains 
Female, 10–12 week-old BALBc mice were used for all experiments. They were raised in the breeding 
facilities of Charles River WIGA (Sulzfeld, Germany) under specified pathogen-free conditions. The 
experiments were performed in the L3 facilities of the Robert Koch-Institute using an IsoCage-System 
(Tecniplast, Hohenpeißenberg, Germany). Mice were infected with 5 × 10
6
 viable Brucella each in 
0.1 ml PBS. Subsequently, on the days 7, 21, and 45, defined groups of 5, 5, and 8 animals, 
respectively, were sacrificed. Spleens were removed and weighed. Numbers of viable bacteria per 
spleen were determined by serial dilutions plated on TSA agar. For statistical analysis, Mann–Whitney 
test was performed by grouping bacterial counts for both strains A (wild type, B. abortus S19) and M 
(Δ-mglA mutant strain, B. abortus S19 A Δ-mglA 3.14) obtained on days 7, 21, and 45 of the mouse 
experiment. 
Immunohistology and cytology 
On days 7, 21, and 45 after infection, the mice were killed and the corresponding parts of spleens 
were removed and immersed in O.C.T. compound (Tissue Tek, Bakura, USA), and kept at −20 °C for 
histologic evaluation. Cryostat sections were fixed in acetone, treated with the respective primary 
antibody, anti-Brucella LPS (Difco, Detroit, MA, USA; 1:100 dil.), and diluted in PBS plus 10% FCS for 
45 min at room temperature in humidified air. Incubation ensued with the secondary antibody, a 
peroxidase-conjugated mouse anti-rabbit IgG (Dianova, Hamburg, Germany) diluted 1:100 for anti-
Brucella, respectively (45 min, room temperature, humidified air). Slides were covered with 100 μl of 
the freshly prepared 3,3′-diaminobenzidine chromogen-substrate solution (Vector, Burlingame, CA, 
USA) containing 0.06% Tris buffer, 0.03% H2O2, at pH 7.6 for approximately 3 min. Finally, the 
sections were washed, counterstained with hematoxylin, and dehydrated. 
 
Results 
Differences in the mglA gene and its flanking regions in the genus Brucella 
In order to further investigate formerly obtained data about mglA-related differences in B. abortus S19 
variants ( Jacob et al., 2006), DNA in the respective target region of chromosome II from B. abortus 
S19 as well as from avirulent B. neotomae 5K33 and B. microti CCM 4915 was amplified and 
sequenced. The data for B. abortus S19 and B. neotomae 5K33 were deposited at GenBank 
(EU402949 and EU410469) and compared with corresponding data from publicly available sequences 
from B. abortus 2308 ( Chain et al., 2005), B. abortus 9–941 ( Halling et al., 2005), B. abortus S19 ( 
Crasta et al., 2008), B. melitensis 16M ( DelVecchio et al., 2002), B. suis ( Paulsen et al., 2002), B. 
ovis ( Wattam et al., 2009), B. canis ( Wattam et al., 2009), Brucella sp. 83/13 
(http://patricbrc.vbi.vt.edu/portal/portal/patric/Taxon?cType=taxon&cId=520449), B. neotomae 5K33 
(http://patricbrc.vbi.vt.edu/portal/portal/patric/Taxon?cType=taxon&cId=520456) as well as with the 
data obtained by sequencing of the respective genes in B. microti CCM 4915, later confirmed by Audic 
et al. (2009). 
For further comparison, the flanking genes BMEII0981 (permease), BMEII0983 (periplasmic protein 
precursor), BMEII0985 (operon repressor), and BMEII0986 (transcriptional regulator, nnrA), as well as 
BMEII0987 (nirV), and BMEII0988 (nitrate reductase precursor, nirK) were also taken into 
consideration. The B. melitensis 16M genome was used as a reference. 
The mglA-DNA sequence of the investigated B. abortus S19 strain was identical to the published 
sequence of B. abortus 9–941 while in B. abortus 2308 mglA is truncated at amino acid (AA) position 
236 ( Fig. 3) ( Chain et al., 2005). The comparison with other Brucella biovars/species revealed that B. 
neotomae, B. ovis, and B. microti show the most complete sequences of the mglA gene while B. 
abortus, including strain B. abortus S19, B. melitensis, B. canis, and B. suis are characterized by 
nucleotide deletions, resulting in the loss or exchange of amino acids at various positions ( Fig. 3). In 
the newly identified species Brucella sp. 83/13 
(http://patricbrc.vbi.vt.edu/portal/portal/patric/Taxon?cType=taxon&cId=520449), mglA as well as its 
flanking genes (operon repressor, periplasmic protein precursor, and permease) are missing ( Fig. 1, 
Table 1). 
However, in contrast to the complete mglA gene, the avirulent B. neotomae 5K33 demonstrates a 
large-scale nucleotide deletion of 2.2 kb including a partial deletion of the genes BMEII0986 and 
BMII0988, respectively, and a complete deletion of BMEII0987 ( Baek et al., 2004) resulting in the loss 
of putative regulator genes (nnrA, nirK, nirV) ( Fig. 1, Table 1). 
Deletion mutagenesis of mglA 
To further investigate the potential role of mglA, we generated a Δ-mglA deletion mutant of the large 
variant of B. abortus S19 A by allelic gene replacement ( Campos et al., 2002, Quandt and Hynes, 
1993 and Pelicic et al., 1996). Successful deletion was confirmed by both PCR ( Fig. 2) and DNA 
sequencing (data not shown). In Fig. 2, lanes 2, 3, and 5 demonstrate the Δ-mglA-specific PCR 
fragment of 1.4 kb size as a result of gene exchange, as compared to the parental strain in lanes 1, 4, 
and 6 (1.6 kb). 
Behaviour on Fe
3+
-containing minimal medium and tolerance to oxidative stress 
Our original investigation (Jacob et al., 2006) was initiated by the observation of a reduced growth rate 
of a small-colony variant of B. abortus S19. We therefore characterized the growth of B. abortus S19 A 
Δ-mglA 3.14 on defined galactose and/or Fe
3+
-containing minimal media. On these media, B. abortus 
S19 A Δ-mglA 3.14 showed a reduced growth (i.e. colony size) whenever Fe
3+
 was present in the 
medium ( Fig. 4). In addition, B. abortus S19 A Δ-mglA 3.14 was characterized by increased tolerance 
to H2O2 (0.3% versus 0.085%, Table 2) and a higher tolerance to a galactose-containing hyperosmotic 
(i.e. toxic) medium (F1) ( Fig. 5). 
In vivo behaviour 
The investigation of the in vivo behaviour of the Δ-mglA mutant mainly focused on differences in the 
persistence of the bacteria in the late phase of infection ( Hort et al., 2003). Mice were infected with 
5 × 10
6
 viable bacteria of B. abortus S19A and its isogenic mglA deletion mutant B. abortus S19 A Δ-
mglA 3.14, and the bacterial load was determined in spleens on days 7, 21, and 45, respectively. 
While the bacterial load was similar on day 45 after infection, the infection with the mglA deletion 
mutant resulted in a slight, but significantly higher bacterial load on day 7 after infection which 
represents the pre-immune phase of the infection ( Fig. 6). 
Immunohistology and cytology 
In order to further investigate the differences in bacterial load on day 7 and day 21, spleens of infected 
mice were investigated by immunohistology using a Brucella-LPS-specific antibody ( Hort et al., 2003). 
Histological alterations in spleens of Brucella-infected mice have been described earlier ( Hort et al., 
2003) and did not differ significantly between the groups investigated in this study (data not shown). 
 
Discussion 
The persistence of bacteria in chronic infections like brucellosis may be due to (i) inadequate host 
responses or (ii) a specific ability of the invader to tolerate (or evade) usually effective defence 
mechanisms. In addition, Brucella-induced inflammatory responses in the spleens of infected animals 
associated with changes in the eradication kinetics of Brucella have been described ( Hort et al., 
2003). In a previous paper, we demonstrated that in B. abortus S19 a gene predicted to encode for a 
formerly described galactoside transport ATP binding protein (mglA) is differentially expressed in 
small- versus large-colony variants which differ in in vivo persistence ( Jacob et al., 2006). In an 
attempt to further investigate the potential role of this gene locus, we analyzed mglA and its flanking 
regions in various members of the genus Brucella. 
Sequencing of the mglA gene of both, the large- and the small-colony variants of strain B. abortus S19 
revealed no differences on the DNA level when compared to the homologous genes of B. abortus 
biovar 1 strain 9–941. Compared to the attenuated vaccine strain B. abortus S19, virulent B. abortus 
2308, however, demonstrates an additional deletion in the mglA gene resulting in the loss of 42 amino 
acids at the C-terminal end at position 236 ff ( Fig. 3). In B. melitensis, a specific difference in the mglA 
gene is present at amino acid position 199–205 while in B. suis and B. canis, there is a deletion of 
amino acids at position 214/215. 
Additional differences in mglA and its flanking regions became prominent when compared to B. 
neotomae and other members of the genus Brucella like B. ovis, B. microti, and Brucella sp. 83/13. 
The B. microti mglA sequence which we obtained was identical to the one from a B. microti whole-
genome sequencing project ( Audic et al., 2009) and, therefore, we did not submit our own results to 
NCBI. 
Data obtained from the investigation of the flanking regions of mglA, especially in putative regulatory 
genes ( Fig. 1, Table 1), revealed that the sequences of B. microti CCM 4915 ( Audic et al., 2009) and 
B. ovis are similar, not only with respect to mglA, but also to the flanking regions. In this context, B. 
ovis is of special interest because of its narrow host range and tissue tropism ( Tsolis et al., 2009), 
while possessing the whole mgl operon. 
In summary, B. neotomae, B. ovis, and B. microti, all characterized by reduced pathogenicity, have the 
most complete mglA gene sequence, while B. melitensis, B. suis, B. canis, and B. abortus are 
characterized by specific deletions. Taken together with differences in the flanking regions, this gene 
locus may thus be interesting not only for diagnostic purposes ( Table 1), but also with respect to 
virulence and pathogenesis. So far, the most relevant difference between the virulent and chronically 
persisting strain B. abortus 2308 and the vaccine strain B. abortus S19 has only been described for 
erythritol-catabolism ( Crasta et al., 2008 and Sangari et al., 2000). Most interestingly, the differences 
in the mglA genome region enable similar conclusions as the results of a phylogenetic ‘clade’ system, 
based on whole-genome comparisons ( Wattam et al., 2009), which describes B. ovis as an ‘ancestor’ 
from which other Brucella species may have diverged from. 
The differences in the mglA sequences within the genus Brucella and the loss of regulatory genes as 
examplified in B. neotomae 5K33 ( Fig. 1 and Fig. 3, Table 1) can be interpreted as a result of ongoing 
genetic rearrangements in this region of chromosome II. Such mechanisms have been described as a 
cause for the generation of strain and species-specific differences within the genus Brucella ( Chain et 
al., 2005, Rajashekara et al., 2005 and Tsoktouridis et al., 2003). 
With respect to functional consequences of differences in this gene region, it is worth mentioning that 
a gene in immediate neighbourhood and functionally related to mglA, the D-galactose-binding 
periplasmic protein precursor (BMEII0983), has been found to be underexpressed in the attenuated 
vaccine strain B. melitensis Rev1 ( Eschenbrenner et al., 2002) and recently in B. abortus 2308 ( 
Lamontagne et al., 2009). Furthermore, the gene nnrA (BMEII0986), which is an immediate neighbour 
of the operon and potentially involved in its regulation ( Fig. 1), has been demonstrated as a virulence 
factor ( Haine et al., 2006). The absence of nnrA (BMEII0986) in the avirulent B. neotomae 5K33 ( 
Baek et al., 2004) has now been confirmed in the context of this study (GenBank acc.no. EU410469). 
However, in the initial paper ( Baek et al., 2004) describing the importance of nnrA, nirV, and nirK for 
virulence, no data were presented for mglA. Data from hybridization studies of the virulent B. 
melitensis and the avirulent B. neotomae demonstrate only 2 significant differences in the genome 
between these organisms ( Baek et al., 2004). One is the region analyzed in more detail here, the 
other one is an additional, possibly Rhizobium-borne gene region ( Rajashekara et al., 2004). 
There are more hints that the region around mglA may be involved in Brucella pathogenicity as the 
genome region upstream of mglA has just been shown by means of DNA microarray as to be poorly 
expressed under laboratory conditions in B. abortus 2308 ( Viadas et al., 2009) (BAB2_0941, 0942, 
0943). In addition, gene norD, upstream of the operon repressor, has also been described to be 
involved in virulence of B. suis ( Loisel-Meyer et al., 2006). 
In B. suis 1330, the gene nosZ (BRA0275) was described by proteomics ( Al Dahouk et al., 2009) as 
to be overexpressed during anaerobic survival. 
In order to substantiate the assumption that mglA may be involved in the tolerance of Brucella to 
hostile environments, we generated an mglA deletion mutant of the large-colony type of B. abortus 
S19 A ( Jacob et al., 2006) and tested it in various in vitro and in vivo assays. The increased tolerance 
of the deletion mutant in a galactose-containing hyperosmotic medium ( Fig. 5) as well as to oxidative 
stress (H2O2) ( Table 2) may be taken as a hint that the region is involved in tolerance to adverse 
environmental conditions ( Köhler et al., 2002 and Köhler et al., 2003). 
Most interestingly, the reduced growth on Fe
3+
-containing minimal media (Fig. 4) revealed an in vitro 
phenotype of the deletion mutant that has previously been described for a spontaneous small-colony 
variant of B. abortus S19 ( Jacob et al., 2006). 
Finally, in vivo experiments were performed in order to identify the effects of mglA deletion on in vivo 
persistence of Brucella. Whilst there was a significant difference in bacterial load of spleens in the pre-
immune phase of the infection, both the vaccine strain S19 and the mglA-deletion mutant did not differ 
in the amount of bacteria present in the late phase of the infection, which is characterized by their 
residence in NO synthase-positive macrophages. 
In conclusion, mglA and its flanking regions may be useful for diagnostic purposes. In addition, 




The intracellular fate of various Brucella strains and mutants differing in the respective gene locus in 
the presence and absence of IFN-γ is the topic of forthcoming investigations. 
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Tables and Figures 
Figure 1.  mglA in the context of its flanking genes in chromosome II of B. melitensis 16M, B. abortus, 
B. neotomae, and Brucella sp. 83/13 (blue arrows indicate identical genes, red arrows indicate 
naturally deleted genes, slightly red arrows indicate partly deleted genes). (For interpretation of the 








Figure 2.  PCR-assisted mglA fragment length analysis of DNA from wild type and deletion mutants of 


























Figure 3.  Formatted alignment of amino acid sequences of mglA from B. neotomae 5K33, B. ovis 
ATCC25840 (BOV_A0241), B. microti CCM 4915, B. canis ATCC 23365 (BCAN_B0267), B. suis 1330 
(BRA0266), B. melitensis 16M (BMEII0982), B. abortus 9–941 (BruAb2_0914), B. abortus 2308 












Figure 4.  Growth characteristics of B. abortus 2308, B. abortus S19A, and B. abortus S19A Δ-mglA 
3.14 on galactose/Fe
3+
-containing minimal medium under aerobic conditions. Equivalent numbers of 
B. abortus 2308, B. abortus S19, and the corresponding mglA deletion mutant (B. abortus S19 Δ-mglA 
3.14) were grown on various defined media: (a) minimal basic medium (MBM), (b) minimal basic 
medium + 10 mmol galactose, (c) minimal basic medium + 1 mmol Fe
3+
, (d) minimal basic 
medium + (galactose/Fe
3+
), and (e) minimal basic medium + 10 mmol erythritol. Differences in 
erythritol metabolism have been described for both B. abortus 2308 and B. abortus S19 ( Crasta et al., 
















Figure 5.  Survival of B. abortus S19 A, B. abortus S19 A Δ-mglA 3.14, and B. neotomae 5K33 in 
hyperosmotic medium F1 with and without 10 mM galactose. A representative experiment out of 3 
independent experiments using triplicates each is presented. Statistical analysis (Mann–Whitney U 
test) revealed that differences in growth kinetics between B. abortus S19 A and B. abortus S19 A Δ-
mglA 3.14 were statistically significant on days 6 and 8 both in the presence of galactose (d6, 





























Figure 6.  Kinetics of bacterial eradication in spleens of BALBc mice infected i.v. with 5 × 10
6
B. 
abortus S19A resp. B. abortus S19A Δ-mglA 3.14 (mutant strain). On days 7, 21, and 45 after 
infection, mice were sacrificed, spleens were homogenized, and bacterial loads were determined by 
plating of serial dilutions on TSA. Statistical analysis (Mann–Whitney U test): (day 7, p = 0.016; day 
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Table 2.  Tolerance of B. abortus 2308, B. abortus S19, and B. abortus S19 ΔmglA 3.14 to H2O2. The 
results show the H2O2 concentrations tolerated by the respective strain in the medium. 
 
 
Tolerance to H202 
B. abortus 2308 0.3 ± 0% 
B. abortus S19 Gr. A 0.085 ± 0.033% 
B. abortus S19 ΔmglA 0.3 ± 0% 
 
